17Β-Estradiol (E 2) was shown to exert neuroprotective effects both in in vitro and in vivo models of stroke. Although these effects of E 2 are known to require estrogen receptor-α (ERα), the cellular target of estrogen-mediated neuroprotection remains unknown. Using cell type-specific ER mutant mice in an in vivo model of stroke, we specifically investigated the role of ERα in neuronal cells versus its role in the microglia in the mediation of neuroprotection by estrogens. We generated and analyzed two different tissue-specific knockout mouse lines lacking ERα either in cells of myeloid lineage, including microglia, or in the neurons of the forebrain. Both E 2-treated and E 2-untreated mutant and control mice were subjected to a permanent middle cerebral artery occlusion for 48 h, and the infarct volume was quantified. Although the infarct volume of E 2-treated female myeloid-specific ERα knockout mice was similar to that of E 2-treated control mice, both male and female neuron-specific ERα mutant mice had larger infarcts than did control mice after E 2 treatment. We conclude that neuronal ERα in female and male mice mediates neuroprotective estrogen effects in an in vivo mouse model of stroke, whereas microglial ERα is dispensable.

Original languageEnglish
JournalJournal of Cerebral Blood Flow and Metabolism
Issue number5
Pages (from-to)935-942
Number of pages8
Publication statusPublished - 01.05.2010

Research Areas and Centers

  • Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)


Dive into the research topics of 'Neuronal estrogen receptor-α mediates neuroprotection by 17Β-estradiol'. Together they form a unique fingerprint.

Cite this